Practice
Featured experience
Applied Aerospace & Defense $650 million IPO
We advised the underwriters on the IPO
Hilton $1 billion senior notes offering
We advised the representative of the initial purchasers on the offering
TE Connectivity $1.4 billion acquisition of Astrodyne TDI
We are advising TE Connectivity on the transaction
Venture Global LNG $2.25 billion senior secured notes offering
We advised Venture Global on its high-yield offering
ON Semiconductor $700 million offering of senior notes
Davis Polk advised the representative of the several initial purchasers in connection with a Rule 144A/Regulation S…
Honeywell International $3 billion senior notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell…
TFI International $218.8 million follow-on offering
Davis Polk advised the joint lead book-running managers in connection with the $218.8 million public offering of 5,060…
Motorola Solutions $900 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of …
Plug Power $314.4 million stock offering
Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 30,675…
Automatic Data Processing $1 billion senior notes offering
Davis Polk advised Automatic Data Processing, Inc. (“ADP”) in connection with its SEC-registered offering of $1 billion…
Schlumberger $350 million notes offering
Davis Polk advised the sole bookrunning manager on an SEC-registered offering by Schlumberger Investment SA of $350 million…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Textron $500 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by…
BioXcel Therapeutics $200 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000…